Pamidronate: a novel treatment for the SAPHO syndrome?

Marshall, H., Bromilow, J., Thomas, A. L. and Arden, N. K. (2002) Pamidronate: a novel treatment for the SAPHO syndrome? Rheumatology, 41, (2), pp. 231-233. (doi:10.1093/rheumatology/41.2.231-a).


Full text not available from this repository.


SIR, The SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis and osteitis) was first described by Chamot et al. in 1987. It can occur at any age but usually appears between childhood and middle age. The most troublesome symptom is bone pain, which most often affects the anterior chest wall. Dermatological features include pustulosis of the palms and soles, pustular psoriasis, acne conglobata or fulminans and hydradenitis suppurativa.

Item Type: Article
Digital Object Identifier (DOI): doi:10.1093/rheumatology/41.2.231-a
ISSNs: 1462-0324 (print)
Related URLs:
ePrint ID: 25787
Date :
Date Event
Date Deposited: 24 Apr 2006
Last Modified: 16 Apr 2017 22:35
Further Information:Google Scholar

Actions (login required)

View Item View Item